{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:29:34Z","timestamp":1773966574401,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2024-00439277"],"award-info":[{"award-number":["RS-2024-00439277"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma &amp; Immunology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.anai.2025.11.028","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T16:43:20Z","timestamp":1764348200000},"page":"295-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical, immunologic, and treatment burden of nonsteroidal anti-inflammatory drug\u2013exacerbated cutaneous disease"],"prefix":"10.1016","volume":"136","author":[{"given":"Dong-Hyeon","family":"Suh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieun","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-June","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Min","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9855-3185","authenticated-orcid":false,"given":"Yooseob","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hae-Sim","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.anai.2025.11.028_bib0001","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jaci.2024.11.039","article-title":"Chronic spontaneous urticaria remission definition and therapy stepping down: World Allergy Organization position paper","volume":"155","author":"Sanchez","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.11.028_bib0002","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13223-020-00459-5","article-title":"Natural history, prognostic factors and patient perceived response to treatment in chronic spontaneous urticaria","volume":"16","author":"Stepaniuk","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.11.028_bib0003","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jaad.2018.01.020","article-title":"Urticaria: a comprehensive review: epidemiology, diagnosis, and work-up","volume":"79","author":"Antia","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.anai.2025.11.028_bib0004","doi-asserted-by":"crossref","first-page":"563","DOI":"10.4168\/aair.2020.12.4.563","article-title":"The KAAACI\/KDA evidence-based practice guidelines for chronic spontaneous urticaria in Korean adults and children: part 1. definition, methodology and first-line management","volume":"12","author":"Song","year":"2020","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"10.1016\/j.anai.2025.11.028_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.70026","article-title":"Disease control and quality of life in chronic spontaneous urticaria and recurrent angioedema are strongly linked, but not in all patients","volume":"15","author":"Neisinger","year":"2025","journal-title":"Clin Transl Allergy"},{"issue":"6","key":"10.1016\/j.anai.2025.11.028_bib0006","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jaip.2021.04.023","article-title":"Triggers of exacerbation in chronic urticaria and recurrent angioedema-prevalence and relevance","volume":"9","author":"Grumach","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2025.11.028_bib0007","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2230.2003.01228.x","article-title":"Aspirin sensitivity and urticaria","volume":"28","author":"Grattan","year":"2003","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.anai.2025.11.028_bib0008","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1385\/CRIAI:24:2:125","article-title":"Cutaneous reactions to aspirin and nonsteroidal antiinflammatory drugs","volume":"24","author":"Sanchez-Borges","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.11.028_bib0009","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3346\/jkms.2008.23.5.845","article-title":"Association of specific IgE to staphylococcal superantigens with the phenotype of chronic urticaria","volume":"23","author":"Ye","year":"2008","journal-title":"J Korean Med Sci"},{"issue":"3","key":"10.1016\/j.anai.2025.11.028_bib0010","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/all.14032","article-title":"Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs","volume":"75","author":"Dona","year":"2020","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2025.11.028_bib0011","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4168\/aair.2015.7.4.312","article-title":"Seven steps to the diagnosis of NSAIDs hypersensitivity: how to apply a new classification in real practice?","volume":"7","author":"Kowalski","year":"2015","journal-title":"Allergy Asthma Immunol Res"},{"issue":"2","key":"10.1016\/j.anai.2025.11.028_bib0012","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jaci.2006.10.006","article-title":"Significant association of FcepsilonRIalpha promoter polymorphisms with aspirin-intolerant chronic urticaria","volume":"119","author":"Bae","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.11.028_bib0013","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.anai.2014.06.011","article-title":"Elevated platelet activation in patients with chronic urticaria: a comparison between aspirin-intolerant and aspirin-tolerant groups","volume":"113","author":"Palikhe","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.11.028_bib0014","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2710.2008.00957.x","article-title":"Association between a TGFbeta1 promoter polymorphism and the phenotype of aspirin-intolerant chronic urticaria in a Korean population","volume":"33","author":"Park","year":"2008","journal-title":"J Clin Pharm Ther"},{"issue":"12","key":"10.1016\/j.anai.2025.11.028_bib0015","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"issue":"6","key":"10.1016\/j.anai.2025.11.028_bib0017","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4168\/aair.2024.16.6.626","article-title":"Distinct clinical profiles of IgE and IgG autoantibodies to thyroid peroxidase in chronic spontaneous urticaria","volume":"16","author":"Jang","year":"2024","journal-title":"Allergy Asthma Immunol Res"},{"issue":"3","key":"10.1016\/j.anai.2025.11.028_bib0018","first-page":"44","article-title":"Efficacy and safety of up-dosed second-generation antihistamines in uncontrolled chronic spontaneous urticaria: a review","volume":"16","author":"Podder","year":"2023","journal-title":"J Clin Aesthet Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2025.11.028_bib0019","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.11.028_bib0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.23822\/EurAnnACI.1764-1489.227","article-title":"Nonsteroidal anti-inflammatory drugs hypersensitivity in chronic spontaneous urticaria in the light of its pathogenesis","volume":"54","author":"Asero","year":"2022","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.11.028_bib0021","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/jdv.12658","article-title":"Aspirin-exacerbated cutaneous disease (AECD) is a distinct subphenotype of chronic spontaneous urticaria","volume":"29","author":"Sanchez-Borges","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.anai.2025.11.028_bib0022","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/all.12260","article-title":"Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs","volume":"68","author":"Kowalski","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2025.11.028_bib0023","first-page":"194","article-title":"Comparison of clinical characteristics and prognosis of chronic urticaria according to the aspirin sensitivity","volume":"25","author":"Ye","year":"2005","journal-title":"Korean J Asthma Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.11.028_bib0024","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0091-6749(96)70102-1","article-title":"Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients","volume":"98","author":"Quiralte","year":"1996","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.11.028_bib0025","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1346-8138.2007.00276.x","article-title":"Chronic idiopathic urticaria: prevalence and clinical course","volume":"34","author":"Kulthanan","year":"2007","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.anai.2025.11.028_bib0026","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA(2)LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2025.11.028_bib0027","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4168\/aair.2023.15.4.496","article-title":"KAAACI Work Group on Urticaria\/Angioedema\/Anaphylaxis. Urticaria\/angioedema\/anaphylaxis KWGo. Efficacy of second-line treatments in chronic urticaria refractory to standard dose antihistamines","volume":"15","author":"Kim","year":"2023","journal-title":"Allergy Asthma Immunol Res"},{"issue":"2","key":"10.1016\/j.anai.2025.11.028_bib0028","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4168\/aair.2021.13.2.171","article-title":"Clinical characteristics of NSAID-induced blended reaction","volume":"13","author":"Hur","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"issue":"2","key":"10.1016\/j.anai.2025.11.028_bib0029","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4168\/aair.2021.13.2.229","article-title":"Clinical characteristics, urinary leukotriene E4 levels, and aspirin desensitization results in patients with NSAID-induced blended reactions","volume":"13","author":"Klaewsongkram","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"issue":"6","key":"10.1016\/j.anai.2025.11.028_bib0030","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jaci.2022.04.010","article-title":"Autoimmune chronic spontaneous urticaria","volume":"149","author":"Kolkhir","year":"2022","journal-title":"J Allergy Clin Immunol"}],"container-title":["Annals of Allergy, Asthma &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625013675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625013675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:27:15Z","timestamp":1773959235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120625013675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1081120625013675"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2025.11.028","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical, immunologic, and treatment burden of nonsteroidal anti-inflammatory drug\u2013exacerbated cutaneous disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2025.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}